• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮酒:医学影响、肝脏及其他方面。

Alcohol Consumption: Medical Implications, the Liver and Beyond.

作者信息

Meza Víctor, Arnold Jorge, Díaz Luis Antonio, Ayala Valverde María, Idalsoaga Francisco, Ayares Gustavo, Devuni Deepika, Arab Juan Pablo

机构信息

Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile.

出版信息

Alcohol Alcohol. 2022 May 10;57(3):283-291. doi: 10.1093/alcalc/agac013.

DOI:10.1093/alcalc/agac013
PMID:35333295
Abstract

Alcohol consumption represents a major factor of morbidity and mortality, with a wide range of adverse medical implications that practically affect every organ system. It is the fifth major cause of deaths in men and women and causes up to 139 million disability-adjusted life years. Solid evidence places the risk as undoubtedly correlated to the length of time and amount of alcohol consumption. While alcohol-related liver disease represents one of the most studied and well-known consequences of alcohol use, the term itself embodies a wide spectrum of progressive disease stages that are responsible for almost half of the liver-related mortality worldwide. We discuss the staged alcohol-related fatty liver, alcohol-related steatohepatitis and, finally, fibrosis and cirrhosis, which ultimately may end up in a hepatocellular carcinoma. Other comorbidities such as acute and chronic pancreatitis; central nervous system; cardiovascular, respiratory and endocrine system; renal disease; urological pathologies; type 2 diabetes mellitus and even infectious diseases are reviewed in their relation to alcohol consumption. This article reviews the impact of alcohol use on different systems and organs, summarizing available evidence regarding its medical implications. It examines current basic and clinical data regarding mechanisms to highlight factors and processes that may be targetable to improve patient outcomes. Although alcohol use is a part of many cultural and social practices, as healthcare providers we must identify populations at high risk of alcohol abuse, educate patients about the potential alcohol-related harm and provide appropriate treatment.

摘要

饮酒是发病和死亡的一个主要因素,具有广泛的不良医学影响,几乎累及每个器官系统。它是男性和女性死亡的第五大主要原因,导致多达1.39亿伤残调整生命年。确凿证据表明,风险无疑与饮酒时间长短和饮酒量相关。虽然酒精性肝病是饮酒最常被研究且最为人所知的后果之一,但该术语本身涵盖了一系列进展性疾病阶段,这些阶段导致了全球近一半的肝脏相关死亡率。我们将讨论分期的酒精性脂肪肝、酒精性脂肪性肝炎,最后是纤维化和肝硬化,它们最终可能发展为肝细胞癌。还将回顾其他合并症,如急性和慢性胰腺炎;中枢神经系统;心血管、呼吸和内分泌系统;肾脏疾病;泌尿系统疾病;2型糖尿病,甚至传染病与饮酒的关系。本文回顾了饮酒对不同系统和器官的影响,总结了有关其医学影响的现有证据。它研究了当前关于机制的基础和临床数据,以突出可能成为改善患者预后靶点的因素和过程。尽管饮酒是许多文化和社会习俗的一部分,但作为医疗服务提供者,我们必须识别出酒精滥用的高危人群,教育患者了解与酒精相关的潜在危害,并提供适当的治疗。

相似文献

1
Alcohol Consumption: Medical Implications, the Liver and Beyond.饮酒:医学影响、肝脏及其他方面。
Alcohol Alcohol. 2022 May 10;57(3):283-291. doi: 10.1093/alcalc/agac013.
2
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).非酒精性脂肪性肝病(NAFLD)和酒精性相关脂肪性肝病(AFLD)患者的死亡原因。
Curr Pharm Des. 2020;26(10):1079-1092. doi: 10.2174/1381612826666200128094231.
3
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease.饮酒和代谢综合征对非酒精性和酒精性脂肪性肝病患者死亡率的影响。
Clin Gastroenterol Hepatol. 2019 Jul;17(8):1625-1633.e1. doi: 10.1016/j.cgh.2018.11.033. Epub 2018 Nov 23.
4
Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.适量饮酒与非酒精性脂肪性肝病的肝纤维化进展有关,并且与 2 型糖尿病有协同作用。
Metabolism. 2021 Feb;115:154439. doi: 10.1016/j.metabol.2020.154439. Epub 2020 Nov 25.
5
Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis.酒精性和非酒精性脂肪性肝炎的病理生理相似性和协同作用。
Dig Dis. 2010;28(6):783-91. doi: 10.1159/000324286. Epub 2011 Apr 27.
6
Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者适度饮酒的影响。
Gut Liver. 2019 May 15;13(3):308-314. doi: 10.5009/gnl18175.
7
Spectrum of Alcoholic Liver Disease.酒精性肝病的谱系
Clin Liver Dis. 2016 Aug;20(3):419-27. doi: 10.1016/j.cld.2016.02.002. Epub 2016 May 31.
8
Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.饮酒类型和模式与非酒精性脂肪性肝病患者的肝纤维化相关。
Am J Gastroenterol. 2018 Oct;113(10):1484-1493. doi: 10.1038/s41395-018-0133-5. Epub 2018 Jun 14.
9
Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis.轻度饮酒习惯是非酒精性脂肪性肝病伴进展性肝纤维化患者发生肝癌的一个危险因素。
World J Gastroenterol. 2018 Apr 7;24(13):1440-1450. doi: 10.3748/wjg.v24.i13.1440.
10
The Effects of Alcohol on Other Chronic Liver Diseases.酒精对其他慢性肝病的影响。
Clin Liver Dis. 2016 Aug;20(3):581-94. doi: 10.1016/j.cld.2016.02.013. Epub 2016 Apr 5.

引用本文的文献

1
The global, regional and national burden of pancreatitis due to alcohol use: Results from the Global Burden of Disease Study 2021 and projections to 2040.酒精所致胰腺炎的全球、区域和国家负担:《2021年全球疾病负担研究》结果及至2040年的预测
PLoS One. 2025 Jul 29;20(7):e0327831. doi: 10.1371/journal.pone.0327831. eCollection 2025.
2
Most vulnerable diet and health profiles: identifying countries at risk through a three-theme clustering.最易受影响的饮食和健康状况:通过三主题聚类识别风险国家。
Front Public Health. 2025 Jul 7;13:1569755. doi: 10.3389/fpubh.2025.1569755. eCollection 2025.
3
Association Between Alcohol Consumption, Other Healthy Habits and Sociodemographic Variables and the Values of Different Insulin Resistance Risk Scales in 139,634 Spanish Workers.
139634名西班牙工人的饮酒量、其他健康习惯和社会人口统计学变量与不同胰岛素抵抗风险量表值之间的关联
Healthcare (Basel). 2025 Apr 17;13(8):921. doi: 10.3390/healthcare13080921.
4
Social/Party Incentives Increase the Risk of Heavier Alcohol Use in Impulsive Individuals.社交/聚会诱因会增加冲动型个体大量饮酒的风险。
Subst Use Misuse. 2025;60(8):1133-1139. doi: 10.1080/10826084.2025.2487981. Epub 2025 Apr 11.
5
Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States.美国酒精性肝病中的性别差异及酒精所致癌症的亚型差异
Clin Mol Hepatol. 2025 Apr 11. doi: 10.3350/cmh.2025.0169.
6
MetALD: New Perspectives on an Old Overlooked Disease.线粒体酒精性肝病:一种被长期忽视的古老疾病的新视角
Liver Int. 2025 May;45(5):e70017. doi: 10.1111/liv.70017.
7
Smartphone-based Stroop Test, EncephalApp: What is the optimal cutoff for diagnosing minimal hepatic encephalopathy?基于智能手机的斯特鲁普测试(EncephalApp):诊断轻微肝性脑病的最佳临界值是多少?
World J Hepatol. 2025 Mar 27;17(3):101649. doi: 10.4254/wjh.v17.i3.101649.
8
Identification of ethanol analgesia quantitative trait loci and candidate genes in BXD recombinant inbred mouse lines.BXD重组近交系小鼠品系中乙醇镇痛数量性状基因座及候选基因的鉴定
Addict Biol. 2025 Feb;30(2):e70013. doi: 10.1111/adb.70013.
9
Current and emerging therapies for alcohol-associated hepatitis.酒精性肝炎的现有及新兴疗法
Liver Res. 2023 Mar 15;7(1):35-46. doi: 10.1016/j.livres.2023.03.002. eCollection 2023 Mar.
10
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease.评估抗白细胞介素23单克隆抗体古塞库单抗在酒精性肝病患者中的安全性和耐受性的临床试验。
Aliment Pharmacol Ther. 2025 Apr;61(7):1140-1151. doi: 10.1111/apt.70026. Epub 2025 Feb 14.